MURC, a Muscle-Restricted Coiled-Coil Protein That Modulates the Rho/ROCK Pathway, Induces Cardiac Dysfunction and Conduction Disturbance

REFERENCES

• Adam, O., G. Frost, F. Custodis, M. A. Sussman, H. J. Schafers, M. Bohm, and U. Laufs. 2007. Role of Rac1 GTPase activation in atrial fibrillation. J. Am. Coll. Cardiol. 50:359–367.
   PubMed Web of Science ®Google Scholar
• Amano, M., Y. Fukata, and K. Kaibuchi. 2000. Regulation and functions of Rho-associated kinase. Exp. Cell. Res. 261:44–51.
   PubMed Web of Science ®Google Scholar
• Aoki, H., S. Izumo, and J. Sadoshima. 1998. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ. Res. 82:666–676.
   PubMedGoogle Scholar
• Arai, A., J. A. Spencer, and E. N. Olson. 2002. STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J. Biol. Chem. 277:24453–24459.
   PubMedGoogle Scholar
• Burgener, R., M. Wolf, T. Ganz, and M. Baggiolini. 1990. Purification and characterization of a major phosphatidylserine-binding phosphoprotein from human platelets. Biochem. J. 269:729–734.
   PubMed Web of Science ®Google Scholar
• Chihara, K., M. Amano, N. Nakamura, T. Yano, M. Shibata, T. Tokui, H. Ichikawa, R. Ikebe, M. Ikebe, and K. Kaibuchi. 1997. Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase. J. Biol. Chem. 272:25121–25127.
   PubMed Web of Science ®Google Scholar
• Churchill, E., G. Budas, A. Vallentin, T. Koyanagi, and D. Mochly-Rosen. 2008. PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu. Rev. Pharmacol. Toxicol. 48:569–599.
   PubMed Web of Science ®Google Scholar
• Clark, K. A., A. S. McElhinny, M. C. Beckerle, and C. C. Gregorio. 2002. Striated muscle cytoarchitecture: an intricate web of form and function. Annu. Rev. Cell Dev. Biol. 18:637–706.
   PubMed Web of Science ®Google Scholar
• Epstein, N. D., and J. S. Davis. 2003. Sensing stretch is fundamental. Cell 112:147–150.
   PubMedGoogle Scholar
• Etienne-Manneville, S., and A. Hall. 2002. Rho GTPases in cell biology. Nature 420:629–635.
   PubMed Web of Science ®Google Scholar
• Everett, T. H. T., and J. E. Olgin. 2007. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 4:S24–S27.
   PubMed Web of Science ®Google Scholar
• Fukata, M., M. Nakagawa, and K. Kaibuchi. 2003. Roles of Rho-family GTPases in cell polarisation and directional migration. Curr. Opin. Cell Biol. 15:590–597.
   PubMed Web of Science ®Google Scholar
• Fuster, V., L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J. Y. Le Heuzey, G. N. Kay, J. E. Lowe, S. B. Olsson, E. N. Prystowsky, J. L. Tamargo, S. Wann, S. C. Smith, Jr., A. K. Jacobs, C. D. Adams, J. L. Anderson, E. M. Antman, S. A. Hunt, R. Nishimura, J. P. Ornato, R. L. Page, B. Riegel, S. G. Priori, J. J. Blanc, A. Budaj, A. J. Camm, V. Dean, J. W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, and J. L. Zamorano. 2006. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation, executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). J. Am. Coll. Cardiol. 48:854–906.
   PubMedGoogle Scholar
• Geneste, O., J. W. Copeland, and R. Treisman. 2002. LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics. J. Cell Biol. 157:831–838.
   PubMed Web of Science ®Google Scholar
• Gratton, J. P., P. Bernatchez, and W. C. Sessa. 2004. Caveolae and caveolins in the cardiovascular system. Circ. Res. 94:1408–1417.
   PubMed Web of Science ®Google Scholar
• Gulick, J., A. Subramaniam, J. Neumann, and J. Robbins. 1991. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J. Biol. Chem. 266:9180–9185.
   PubMedGoogle Scholar
• Gustincich, S., and C. Schneider. 1993. Serum deprivation response gene is induced by serum starvation but not by contact inhibition. Cell Growth Differ. 4:753–760.
   PubMedGoogle Scholar
• Gustincich, S., P. Vatta, S. Goruppi, M. Wolf, S. Saccone, G. Della Valle, M. Baggiolini, and C. Schneider. 1999. The human serum deprivation response gene (SDPR) maps to 2q32-q33 and codes for a phosphatidylserine-binding protein. Genomics 57:120–129.
   PubMed Web of Science ®Google Scholar
• Hagendorff, A., B. Schumacher, S. Kirchhoff, B. Luderitz, and K. Willecke. 1999. Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 99:1508–1515.
   PubMed Web of Science ®Google Scholar
• Hill, C. S., J. Wynne, and R. Treisman. 1995. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159–1170.
   PubMed Web of Science ®Google Scholar
• Hines, W. A., J. Thorburn, and A. Thorburn. 1999. A low-affinity serum response element allows other transcription factors to activate inducible gene expression in cardiac myocytes. Mol. Cell. Biol. 19:1841–1852.
   PubMedGoogle Scholar
• Hoshijima, M. 2006. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am. J. Physiol. Heart Circ. Physiol. 290:H1313–H1325.
   PubMed Web of Science ®Google Scholar
• Hoshijima, M., V. P. Sah, Y. Wang, K. R. Chien, and J. H. Brown. 1998. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J. Biol. Chem. 273:7725–7730.
   PubMedGoogle Scholar
• Houweling, A. C., M. M. van Borren, A. F. Moorman, and V. M. Christoffels. 2005. Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. Cardiovasc. Res. 67:583–593.
   PubMedGoogle Scholar
• Kasahara, H., T. Ueyama, H. Wakimoto, M. K. Liu, C. T. Maguire, K. L. Converso, P. M. Kang, W. J. Manning, J. Lawitts, D. L. Paul, C. I. Berul, and S. Izumo. 2003. Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. J. Mol. Cell. Cardiol. 35:243–256.
   PubMed Web of Science ®Google Scholar
• Kasahara, H., H. Wakimoto, M. Liu, C. T. Maguire, K. L. Converso, T. Shioi, W. Y. Huang, W. J. Manning, D. Paul, J. Lawitts, C. I. Berul, and S. Izumo. 2001. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. J. Clin. Investig. 108:189–201.
   PubMed Web of Science ®Google Scholar
• Kawamura, S., S. Miyamoto, and J. H. Brown. 2003. Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. J. Biol. Chem. 278:31111–31117.
   PubMed Web of Science ®Google Scholar
• Kuwahara, K., G. C. Teg Pipes, J. McAnally, J. A. Richardson, J. A. Hill, R. Bassel-Duby, and E. N. Olson. 2007. Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J. Clin. Investig. 117:1324–1334.
   PubMedGoogle Scholar
• McMullen, J. R., T. Shioi, L. Zhang, O. Tarnavski, M. C. Sherwood, P. M. Kang, and S. Izumo. 2003. Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 100:12355–12360.
   PubMed Web of Science ®Google Scholar
• Mineo, C., Y. S. Ying, C. Chapline, S. Jaken, and R. G. Anderson. 1998. Targeting of protein kinase Cα to caveolae. J. Cell Biol. 141:601–610.
   PubMed Web of Science ®Google Scholar
• Muslin, A. J. 2005. Role of Raf proteins in cardiac hypertrophy and cardiomyocyte survival. Trends Cardiovasc. Med. 15:225–229.
   PubMed Web of Science ®Google Scholar
• Narumiya, S., and S. Yasuda. 2006. Rho GTPases in animal cell mitosis. Curr. Opin. Cell Biol. 18:199–205.
   PubMed Web of Science ®Google Scholar
• Ogata, T., T. Ueyama, T. Nomura, S. Asada, M. Tagawa, T. Nakamura, T. Takahashi, H. Matsubara, and H. Oh. 2007. Osteopontin is a myosphere-derived secretory molecule that promotes angiogenic progenitor cell proliferation through the phosphoinositide 3-kinase/Akt pathway. Biochem. Biophys. Res. Commun. 359:341–347.
   PubMedGoogle Scholar
• Parlakian, A., C. Charvet, B. Escoubet, M. Mericskay, J. D. Molkentin, G. Gary-Bobo, L. J. De Windt, M. A. Ludosky, D. Paulin, D. Daegelen, D. Tuil, and Z. Li. 2005. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Circulation 112:2930–2939.
   PubMed Web of Science ®Google Scholar
• Pyle, W. G., and R. J. Solaro. 2004. At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. Circ. Res. 94:296–305.
   PubMed Web of Science ®Google Scholar
• Saba, S., A. M. Janczewski, L. C. Baker, V. Shusterman, E. C. Gursoy, A. M. Feldman, G. Salama, C. F. McTiernan, and B. London. 2005. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-α. Am. J. Physiol. Heart Circ. Physiol. 289:H1456–H1467.
   PubMed Web of Science ®Google Scholar
• Sah, V. P., S. Minamisawa, S. P. Tam, T. H. Wu, G. W. Dorn, 2nd, J. Ross, Jr., K. R. Chien, and J. H. Brown. 1999. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J. Clin. Investig. 103:1627–1634.
   PubMedGoogle Scholar
• Sawaya, S. E., Y. S. Rajawat, T. G. Rami, G. Szalai, R. L. Price, N. Sivasubramanian, D. L. Mann, and D. S. Khoury. 2007. Downregulation of connexin 40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am. J. Physiol. Heart Circ. Physiol. 292:H1561–H1567.
   PubMed Web of Science ®Google Scholar
• Shioi, T., P. M. Kang, P. S. Douglas, J. Hampe, C. M. Yballe, J. Lawitts, L. C. Cantley, and S. Izumo. 2000. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19:2537–2548.
   PubMed Web of Science ®Google Scholar
• Stace, C. L., and N. T. Ktistakis. 2006. Phosphatidic acid- and phosphatidylserine-binding proteins. Biochim. Biophys. Acta 1761:913–926.
   PubMed Web of Science ®Google Scholar
• Ueyama, T., H. Kasahara, T. Ishiwata, Q. Nie, and S. Izumo. 2003. Myocardin expression is regulated by Nkx2.5, and its function is required for cardiomyogenesis. Mol. Cell. Biol. 23:9222–9232.
   PubMedGoogle Scholar
• Ueyama, T., H. Kasahara, T. Ishiwata, N. Yamasaki, and S. Izumo. 2003. Csm, a cardiac-specific isoform of the RNA helicase Mov10l1, is regulated by Nkx2.5 in embryonic heart. J. Biol. Chem. 278:28750–28757.
   PubMedGoogle Scholar
• Ueyama, T., S. Kawashima, T. Sakoda, Y. Rikitake, T. Ishida, M. Kawai, T. Yamashita, S. Ishido, H. Hotta, and M. Yokoyama. 2000. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J. Mol. Cell. Cardiol. 32:947–960.
   PubMedGoogle Scholar
• Ueyama, T., T. Sakoda, S. Kawashima, E. Hiraoka, K. Hirata, H. Akita, and M. Yokoyama. 1997. Activated RhoA stimulates c-fos gene expression in myocardial cells. Circ. Res. 81:672–678.
   PubMed Web of Science ®Google Scholar
• Velculescu, V. E., B. Vogelstein, and K. W. Kinzler. 2000. Analysing uncharted transcriptomes with SAGE. Trends Genet. 16:423–425.
   PubMed Web of Science ®Google Scholar
• Verheule, S., T. Sato, T. t. Everett, S. K. Engle, D. Otten, M. Rubart-von der Lohe, H. O. Nakajima, H. Nakajima, L. J. Field, and J. E. Olgin. 2004. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-β1. Circ. Res. 94:1458–1465.
   PubMed Web of Science ®Google Scholar
• Wei, L., G. E. Taffet, D. S. Khoury, J. Bo, Y. Li, A. Yatani, M. C. Delaughter, R. Klevitsky, T. E. Hewett, J. Robbins, L. H. Michael, M. D. Schneider, M. L. Entman, and R. J. Schwartz. 2004. Disruption of Rho signaling results in progressive atrioventricular conduction defects while ventricular function remains preserved. FASEB J. 18:857–859.
   PubMedGoogle Scholar
• Xiao, H. D., S. Fuchs, D. J. Campbell, W. Lewis, S. C. Dudley, Jr., V. S. Kasi, B. D. Hoit, G. Keshelava, H. Zhao, M. R. Capecchi, and K. E. Bernstein. 2004. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am. J. Pathol. 165:1019–1032.
   PubMed Web of Science ®Google Scholar
• Zhang, X., G. Azhar, J. Chai, P. Sheridan, K. Nagano, T. Brown, J. Yang, K. Khrapko, A. M. Borras, J. Lawitts, R. P. Misra, and J. Y. Wei. 2001. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am. J. Physiol. Heart Circ. Physiol. 280:H1782–H1792.
   PubMedGoogle Scholar
• Zhang, X., J. Chai, G. Azhar, P. Sheridan, A. M. Borras, M. C. Furr, K. Khrapko, J. Lawitts, R. P. Misra, and J. Y. Wei. 2001. Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J. Biol. Chem. 276:40033–40040.
   PubMedGoogle Scholar